Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Han Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0014-4675; OpenAlex author ID A5100349032. Sources: OpenAlex.

Their work

Papers
17 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
41
Papers, trials and grants by year

2011: 4 papers · 2012: 3 papers · 2013: 2 papers · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 17

  1. Key oxidized lipid metabolites in pancreatic cancer tissue and metastasis based on metabolomics analysis. Co-author DOI 10.1016/j.bbrc.2025.152900↗
  2. KRAS G12D mutation eliminates reactive oxygen species through the Nrf2/CSE/H 2S axis and contributes to pancreatic cancer growth. Co-author DOI 10.3724/abbs.2022173↗
  3. An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma. First author DOI 10.18632/aging.203323↗
  4. The potential drug for treatment in pancreatic adenocarcinoma: a bioinformatical study based on distinct drug databases. Co-author DOI 10.1186/s13020-020-00309-x↗
  5. The nine ADAMs family members serve as potential biomarkers for immune infiltration in pancreatic adenocarcinoma. First author DOI 10.7717/peerj.9736↗
  6. Bioinformatic evidences and analysis of putative biomarkers in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.heliyon.2019.e02378↗
  7. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3906-0↗
  8. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-3426↗
  9. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. Co-author DOI 10.1158/1541-7786.mcr-12-0609↗
  10. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Co-author DOI 10.1186/1476-4598-12-66↗
  11. Role of glial cell line-derived neurotrophic factor in perineural invasion of pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2012.03.010↗
  12. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathw… Co-author DOI 10.1016/j.canlet.2012.02.035↗
  13. The bidirectional interation between pancreatic cancer and diabetes. Co-author DOI 10.1186/1477-7819-10-171↗
  14. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells. Co-author DOI 10.1007/s11010-010-0617-0↗
  15. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. Co-author DOI 10.1016/j.ejphar.2011.04.055↗
  16. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. Co-author DOI 10.1371/journal.pone.0017385↗
  17. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Co-author DOI 10.1371/journal.pone.0027074↗

Closest collaborators

The 25 strongest of 41 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shilin Xia · 4 shared papers, 2019–2021 · strength 0.45
  2. Bing Qi · 3 shared papers, 2020–2021 · strength 0.35
  3. Qingyong Ma · 10 shared papers, 2011–2014 · strength 0.33
  4. Shuo Wang · 1 shared paper, 2025 · strength 0.25
  5. Xiaozhong Guo · 1 shared paper, 2025 · strength 0.25
  6. Hezhi Wang · 1 shared paper, 2025 · strength 0.25
  7. Xueying Shi · 2 shared papers, 2020–2021 · strength 0.24
  8. Erxi Wu · 7 shared papers, 2011–2014 · strength 0.21
  9. Qinhong Xu · 6 shared papers, 2011–2014 · strength 0.19
  10. Xuqi Li · 5 shared papers, 2012–2014 · strength 0.17
  11. Wei Li · 5 shared papers, 2011–2014 · strength 0.16
  12. Kun Fan · 1 shared paper, 2022 · strength 0.15
  13. Houbao Liu · 1 shared paper, 2022 · strength 0.15
  14. Qi Zhou · 1 shared paper, 2021 · strength 0.13
  15. Ji Li · 1 shared paper, 2021 · strength 0.13
  16. Yajun Gu · 1 shared paper, 2021 · strength 0.13
  17. Wanxing Duan · 4 shared papers, 2012–2014 · strength 0.13
  18. Liang Han · 4 shared papers, 2011–2013 · strength 0.12
  19. Fangyue Guo · 1 shared paper, 2020 · strength 0.11
  20. Lei Yao · 1 shared paper, 2020 · strength 0.11
  21. Yuan Yuan · 1 shared paper, 2020 · strength 0.11
  22. Yuan Gu · 1 shared paper, 2019 · strength 0.10
  23. Hiroyuki Kobayashi · 1 shared paper, 2019 · strength 0.10
  24. Jianjun Lei · 3 shared papers, 2012–2014 · strength 0.10
  25. Junhui Li · 2 shared papers, 2011–2012 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.